Duodenal somatostatinoma

disease
On this page

Also known as duodenal delta cell somatostatin producing tumourduodenal somatostatin producing tumorduodenal somatostatin producing tumourduodenal somatostatin-producing NETduodenal somatostatin-producing neuroendocrine tumorduodenal somatostatin-producing neuroendocrine tumour

Summary

Duodenal somatostatinoma (MONDO:0004236) is a disease. A subtype of duodenal neuroendocrine tumor, well differentiated, low or intermediate grade — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical nameduodenal somatostatinoma
Mondo IDMONDO:0004236
DOIDDOID:7479
NCITC27407
UMLSC1333320
MedGen234205
GARD0023892
Is cancer (heuristic)no

Also known as: duodenal delta cell somatostatin producing tumour · duodenal somatostatin producing tumor · duodenal somatostatin producing tumour · duodenal somatostatin-producing NET · duodenal somatostatin-producing neuroendocrine tumor · duodenal somatostatin-producing neuroendocrine tumour · duodenal somatostatinoma

Disease family

Classification path: disease › human disease › disease by body system or component › digestive system disorderdigestive system neuroendocrine neoplasmdigestive system neuroendocrine tumor, grade 1/2small intestine neuroendocrine tumor, well differentiated, low or intermediate grade › duodenal neuroendocrine tumor, well differentiated, low or intermediate grade › duodenal somatostatinoma

Related subtypes (1): duodenal gastrin-producing neuroendocrine tumor

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.